Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies
Schizophrenia Bulletin · 28.06.2024
DOI: 10.1093/schbul/sbae101 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Schizophrenia Bulletin, online erschienen am 28.06.2024. Verfasst von Salsabil Siddiqui und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Hypothesis Substance use is highly prevalent among people with schizophrenia (SCZ) and related disorders, however, there is no broad-spectrum pharmacotherapy that concurrently addresses both addiction and psychotic symptoms. Psychosocial (PS) interventions, which have yielded promising results in treating psychosis and substance dependence separately, demonstrate potential but have not been systematically evaluated when combined. Study Design Systematic review and random-effects meta-analyses of randomized controlled trials (RCTs) investigating PS interventions for individuals with comorbid substance use and psychotic disorders, encompassing SCZ and schizophrenia spectrum disorders (SSD). We included relevant studies published from MEDLINE, PsycINFO, and Google Scholar through May 2023. Study Results We included 35 RCTs (5176 participants total; approximately 2840 with SSD). Intervention durations ranged from 30 min to 3 years. Meta-analysis did not identify a statistically significant pooled PS intervention effect on the main primary outcome, substance use (18 studies; 803 intervention, 733 control participants; standardized mean difference, −0.05 standard deviation [SD]; 95% CI, −0.16, 0.07 SD; I2 = 18%). PS intervention effects on other outcomes were also not statistically significant. Overall GRADE certainty of evidence was low. Conclusions At present, the literature lacks sufficient evidence supporting the use of PS interventions as opposed to alternative therapeutic approaches for significantly improving substance use, symptomatology, or functioning in people with SCZ and related disorders. However, firm conclusions were precluded by low certainty of evidence. Further RCTs are needed to determine the efficacy of PS treatments for people with dual-diagnoses (DD), either alone or in combination with pharmacotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
- Centre for Addiction and Mental Health (CAMH), Toronto, Canada.
- Department of Family and Community Medicine, University of Toronto, Toronto, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada.
- Dalla Lana School of Public Health, Toronto, Canada.
- Institute of Mental Health Policy Research, Campbell Family Research Institute, CAMH, Toronto, Canada.
ORCID-Profile: Salsabil Siddiqui, Peter Selby, Marco Solmi
Zitieren
APA
Siddiqui, S., Mehta, D., Coles, A., Selby, P., Solmi, M., & Castle, D. (2024). Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies. Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbae101
Vancouver
Siddiqui S, Mehta D, Coles A, Selby P, Solmi M, Castle D. Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies. Schizophrenia Bulletin. 2024. doi:10.1093/schbul/sbae101
BibTeX
@article{Siddiqui2024,
author = {Siddiqui, Salsabil and Mehta, Dhvani and Coles, Alexandria and Selby, Peter and Solmi, Marco and Castle, David},
title = {Psychosocial Interventions for Individuals With Comorbid Psychosis and Substance Use Disorders: Systematic Review and Meta-analysis of Randomized Studies},
journal = {Schizophrenia Bulletin},
year = {2024},
doi = {10.1093/schbul/sbae101}
}
EUVIMED